Insider · CIK 0001256126

Mueller Peter

CIK 0001256126 Name as filed on the most recent filing

Filed as Mueller Peter (71)

130 transaction lines · from 71 filings · filed 2005-12-21 to 2019-08-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

130 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-08-23 P, Open-market purchase BioXcel Therapeutics, Inc.BTAI 14,514, acquired Open Form 4 filing 0001104659-19-047308
2019-08-22 P, Open-market purchase BioXcel Therapeutics, Inc.BTAI 58,684, acquired Open Form 4 filing 0001104659-19-047150
2019-08-21 P, Open-market purchase BioXcel Therapeutics, Inc.BTAI 15,156, acquired Open Form 4 filing 0001104659-19-047150
2018-12-07 P, Open-market purchase BioXcel Therapeutics, Inc.BTAI 2 lines 37,069, acquired Open Form 4 filing 0001104659-18-071881
2018-12-06 P, Open-market purchase BioXcel Therapeutics, Inc.BTAI 2 lines 6,976, acquired Open Form 4 filing 0001104659-18-071881
2018-12-04 P, Open-market purchase BioXcel Therapeutics, Inc.BTAI 5 lines 20,544, acquired Open Form 4 filing 0001104659-18-071741
2014-06-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 4 lines 512,352, disposed Open Form 4 filing 0001209191-14-042313
2014-05-14 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 505,849, disposed Open Form 4 filing 0001209191-14-034624
2014-04-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 4 lines 462,207, disposed Open Form 4 filing 0001209191-14-028131
2014-03-17 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 587,145, disposed Open Form 4 filing 0001209191-14-021850
2014-02-18 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 619,442, disposed Open Form 4 filing 0001209191-14-012316
2014-01-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 590,025, disposed Open Form 4 filing 0001209191-14-003731
2013-12-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 485,142, disposed Open Form 4 filing 0001209191-13-057361
2013-12-12 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 189,892, disposed Open Form 4 filing 0001209191-13-056698
2013-11-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 469,606, disposed Open Form 4 filing 0001209191-13-053081
2013-10-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 549,365, disposed Open Form 4 filing 0001209191-13-048645
2013-09-16 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 4 lines 579,160, disposed Open Form 4 filing 0001209191-13-044599
2013-08-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 580,560, disposed Open Form 4 filing 0001209191-13-041331
2013-07-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 647,517, disposed Open Form 4 filing 0001209191-13-037015
2013-07-02 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 9,758,932, disposed Open Form 4 filing 0001209191-13-035485
2012-10-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 2 lines 344,015, disposed Open Form 4 filing 0001209191-12-049586
2012-09-17 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 373,880, disposed Open Form 4 filing 0001209191-12-046196

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 12
  • Open-market sale 118
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. MUELLER PETER, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001256126

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.